Upgrade to SI Premium - Free Trial

Assertio Holdings (ASRT)

23.49 +0.03 (0.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Shareholder Alert: Ademi LLP investigates whether Assertio Holdings Inc. is obtaining a Fair Price for Public Shareholders June 8, 2026 10:17 PM - StreetInsider Form SCHEDULE 13G/A Assertio Holdings, Inc. Filed by: Nantahala Capital Management, LLC June 2, 2026 4:31 PM - SEC Filing Form SC 14D9 Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 18, 2026 5:18 PM - SEC Filing Form SC TO-T Assertio Holdings, Inc. Filed by: Zydus Lifesciences Ltd. May 18, 2026 4:11 PM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 18, 2026 9:26 AM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 18, 2026 9:25 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: May 18 May 18, 2026 9:24 AM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 13 Filed by: Mason Heather L May 15, 2026 6:00 PM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Zydus Lifesciences Ltd. May 14, 2026 8:46 AM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 13, 2026 5:18 PM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 13, 2026 9:05 AM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 13, 2026 9:04 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: May 13 May 13, 2026 9:04 AM - SEC Filing Assertio Therapeutics (ASRT) PT Raised to $23.50 at Lake Street May 13, 2026 8:47 AM - StreetInsider Zydus to acquire Assertio for $23.50 per share in $166.4 million deal May 13, 2026 8:00 AM - StreetInsider Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash May 13, 2026 8:00 AM - BizWire Form 10-Q Assertio Holdings, Inc. For: Mar 31 May 8, 2026 4:12 PM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 8, 2026 8:16 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: May 07 May 8, 2026 8:13 AM - SEC Filing Assertio and Garda delay tender offer launch to May 14 May 8, 2026 8:00 AM - StreetInsider Assertio and Garda Mutually Agree to Delay Launch of Tender Offer May 8, 2026 8:00 AM - BizWire Form 8-K Assertio Holdings, Inc. For: May 05 May 7, 2026 5:01 PM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 05 Filed by: Stark David Matthew May 6, 2026 6:07 PM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 05 Filed by: Emany Sravan Kumar May 6, 2026 6:05 PM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 05 Filed by: Kirk Sigurd May 6, 2026 6:04 PM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 05 Filed by: MCKEE WILLIAM May 6, 2026 6:02 PM - SEC Filing Form 4 Assertio Holdings, Inc. For: May 05 Filed by: Mason Heather L May 6, 2026 6:00 PM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 5, 2026 9:09 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: May 04 May 5, 2026 9:08 AM - SEC Filing Assertio and Garda postpone tender offer start to May 8, 2026 May 5, 2026 9:01 AM - StreetInsider Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer May 5, 2026 9:00 AM - BizWire Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 4, 2026 8:27 AM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. May 4, 2026 8:23 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: May 01 May 4, 2026 8:21 AM - SEC Filing Assertio raises tender offer price to $21.80 per share in Garda deal May 4, 2026 8:02 AM - StreetInsider Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics May 4, 2026 8:00 AM - BizWire Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 29, 2026 5:09 PM - SEC Filing Form 8-K Assertio Holdings, Inc. For: Apr 29 April 29, 2026 5:08 PM - SEC Filing Assertio and Garda Mutually Agree to Extend Tender Offer Deadline April 29, 2026 4:30 PM - BizWire Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 21, 2026 5:16 PM - SEC Filing Form 8-K Assertio Holdings, Inc. For: Apr 21 April 21, 2026 5:15 PM - SEC Filing Assertio Provides Update on Garda Therapeutics Tender Process April 21, 2026 5:00 PM - BizWire Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 14, 2026 5:10 PM - SEC Filing Form 8-K Assertio Holdings, Inc. For: Apr 08 April 14, 2026 4:41 PM - SEC Filing Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 9, 2026 5:24 PM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 9, 2026 5:16 PM - SEC Filing Form 8-K/A Assertio Holdings, Inc. For: Apr 08 April 9, 2026 5:15 PM - SEC Filing Maxim Group Downgrades Assertio Therapeutics (ASRT) to Hold April 9, 2026 1:42 PM - StreetInsider Lake Street Downgrades Assertio Therapeutics (ASRT) to Hold April 9, 2026 8:43 AM - StreetInsider Form SC14D9C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 9, 2026 8:12 AM - SEC Filing Form SC TO-C Assertio Holdings, Inc. Filed by: Assertio Holdings, Inc. April 9, 2026 8:11 AM - SEC Filing Form 8-K Assertio Holdings, Inc. For: Apr 08 April 9, 2026 8:07 AM - SEC Filing H.C. Wainwright Downgrades Assertio Therapeutics (ASRT) to Neutral April 9, 2026 6:05 AM - StreetInsider Cosette Pharmaceuticals acquires SYMPAZAN and six other branded drugs April 8, 2026 4:10 PM - StreetInsider Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio April 8, 2026 4:10 PM - BizWire Assertio agrees to $125.1 million Garda Therapeutics acquisition April 8, 2026 4:04 PM - StreetInsider Assertio Announces Agreement to be Acquired by Garda Therapeutics April 8, 2026 4:04 PM - BizWire Form SCHEDULE 13G/A Assertio Holdings, Inc. Filed by: Nantahala Capital Management, LLC April 7, 2026 4:39 PM - SEC Filing Form ARS Assertio Holdings, Inc. For: Dec 31 April 7, 2026 12:34 PM - SEC Filing Form DEF 14A Assertio Holdings, Inc. For: May 05 April 6, 2026 5:26 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Assertio Therapeutics (ASRT) March 18, 2026 7:54 AM - StreetInsider Assertio Therapeutics (ASRT) Misses Q4 EPS by 99c March 16, 2026 5:19 PM - StreetInsider Assertio Therapeutics (ASRT) Misses Q4 EPS by 99c March 16, 2026 5:19 PM - StreetInsider Form 10-K Assertio Holdings, Inc. For: Dec 31 March 16, 2026 5:07 PM - SEC Filing Form 8-K Assertio Holdings, Inc. For: Mar 16 March 16, 2026 4:07 PM - SEC Filing Assertio Reports Fourth Quarter and Full Year 2025 Financial Results March 16, 2026 4:05 PM - BizWire Full Article List